Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes
Patients who present with type 2 diabetes and PAD often face substantial mobility issues. According to new data presented at ACC.25, however, treatment with semaglutide could represent a major step forward for this high-risk population.
FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths
One product is being pulled from the market, and the other is receiving updated instructions for use.
AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs
Researchers developed several new AI models that could guide the management of patients with non-valvular atrial fibrillation. There is still some work to do in terms of accuracy, but they already appear to outperform the traditional risk scores being used today.
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension
The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH.
Philips pulls endovascular devices from market after safety issues prompt Class I recall
Philips is recalling all sizes of its Tack Endovascular System after 20 patient injuries were reported. Interventional cardiologists are urged to stop using the device immediately.

Up close and personal: Detailed cellular map of the heart offers ‘a goldmine of information’

The map, part of a study published in Nature, can provide new details about cellular structure and how cells interact with one another. It could even help with the treatment of COVID-19.

Stroke patients with COVID-19 experience more severe symptoms, a much higher mortality rate

It also takes longer for stroke patients to fully recover when they have COVID-19.

Smoking associated with fatal bleeding in the brain

The study, published in Stroke, focused on data from more than 16,000 pairs of twins born from 1958 to 1974.

Blood thinners and COVID-19: Researchers from 100-plus sites join forces for new clinical trials

“There is currently no standard of care for anticoagulation in hospitalized COVID-19 patients, and there is a desperate need for clinical evidence to guide practice,” one NIH official said.

IVL for calcified lesions: Where the technology stands now and where it's headed

In a new analysis, researchers highlighted IVL’s potential for helping with the treatment of coronary artery disease.

Why COVID-19 is, in fact, a microvascular disease—and what that means for clinicians

The combination of inflammation and thrombosis is crucial, suggesting that endothelial dysfunction could be at the heart of this complex infection.

New discovery might explain why blood clots are so common among COVID-19 patients

The team's analysis also examines why blood-thinning medications aren't effectively preventing the clots.

A winning strategy for blood transfusions among anemic heart attack patients

Researchers detailed a method that improves patient safety and leads to significant cost savings.

Vascular & Endovascular

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes

FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths

AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs

ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

Philips pulls endovascular devices from market after safety issues prompt Class I recall